Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · see citing works

Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression

Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H., Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.033 · Cited by 2,123 · see citing works

NF‐κB and the link between inflammation and cancer

DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,490 · see citing works

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · see citing works

Cell cycle kinases as therapeutic targets for cancer

Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 906 · see citing works

The diverse and complex roles of NF-κB subunits in cancer

Perkins, N. D. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3204 · Cited by 845 · see citing works

Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Meyerson, M. M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 799 · see citing works

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793 · see citing works

Cyclin D-dependent kinases, INK4 inhibitors and cancer

Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 774 · see citing works

The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor.

Beyaert, R., Cuenda, A., Berghe, W. V., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., & Fiers, W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00542.x · Cited by 650 · see citing works

Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation

Hargreaves, D. C., Horng, T., & Medzhitov, R. M. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 649 · see citing works

The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells

Collombat, P., Xu, X., Ravassard, P., Sosa‐Pineda, B., Dussaud, S., Billestrup, N., Madsen, O. D., Serup, P., Heimberg, H., & Mansouri, A. (2009) · Cell · doi:10.1016/j.cell.2009.05.035 · Cited by 548 · see citing works

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543 · see citing works

Common variants at CD40 and other loci confer risk of rheumatoid arthritis

Raychaudhuri, S., Remmers, E. F., Lee, A. T., Hackett, R., Guiducci, C., Burtt, N. P., Gianniny, L., Korman, B. D., Padyukov, L., Kurreeman, F. A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.233 · Cited by 534 · see citing works

Moonlighting proteins: An intriguing mode of multitasking

Huberts, D. H. E. W., & van der Klei, I. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.022 · Cited by 456 · see citing works

Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II

Larochelle, S., Amat, R., Glover-Cutter, K. M., Sansó, M., Zhang, C., Allen, J. J., Shokat, K. M., Bentley, D. L., & Fisher, R. P. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2399 · Cited by 394 · see citing works

Targeting of TAK1 in inflammatory disorders and cancer

Sakurai, H. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.06.007 · Cited by 377 · see citing works

Interleukin-1 (IL-1) Pathway

Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm1 · Cited by 353 · see citing works

The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line

Adey, A., Burton, J. N., Kitzman, J. O., Hiatt, J. B., Lewis, A. P., Martin, B., Qiu, R., Lee, C., & Shendure, J. (2013) · Nature · doi:10.1038/nature12064 · Cited by 345 · see citing works

Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway

Huang, B., Yang, X., Lamb, A., & Chen, L. F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.017 · Cited by 345 · see citing works

PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit

Tanaka, T., Grusby, M. J., & Kaisho, T. (2007) · Nature Immunology · doi:10.1038/ni1464 · Cited by 326 · see citing works

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.012 · Cited by 313 · see citing works

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388298 · Cited by 299 · see citing works

Signaling through cyclin D-dependent kinases

Choi, Y., & Anders, L. (2013) · Oncogene · doi:10.1038/onc.2013.137 · Cited by 279 · see citing works

Interactions of NF-κB with chromatin: the art of being at the right place at the right time

Natoli, G., Saccani, S., Bosisio, D., & Marazzi, I. (2005) · Nature Immunology · doi:10.1038/ni1196 · Cited by 250 · see citing works

NF‐κB: A Multifaceted Transcription Factor Regulated at Several Levels

Schmitz, M. L., Mattioli, I., Buss, H., & Kracht, M. (2004) · ChemBioChem · doi:10.1002/cbic.200400144 · Cited by 244 · see citing works

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

Wiedemeyer, W. R., Dunn, I. F., Quayle, S. N., Zhang, J., Chheda, M. G., Dunn, G. P., Zhuang, L., Rosenbluh, J., Chen, S., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001613107 · Cited by 223 · see citing works

Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop

Yang, P. X., Guo, L., Duan, Z., Tepper, C. G., Xue, L., Chen, X., Kung, H., Gao, A. C., Zou, J. X., & Chen, H.-W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00204-12 · Cited by 145 · see citing works

Inducible Phosphorylation of NF-κB p65 at Serine 468 by T Cell Costimulation Is Mediated by IKKϵ

Mattioli, I., Geng, H. Z., Sebald, A., Hodel, M., Bucher, C., Kracht, M., & Schmitz, M. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508045200 · Cited by 124 · see citing works

The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB

Ziesché, E., Kettner-Buhrow, D., Weber, A., Wittwer, T., Jurida, L., Meier‐Soelch, J., Müller, H., Newel, D., Kronich, P., Schneider, H., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks916 · Cited by 123 · see citing works

A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promotersPreprint

Kassel, O., Schneider, S., Heilbock, C., Litfin, M., Göttlicher, M., & Herrlich, P. A. (2004) · Genes & Development · doi:10.1101/gad.322404 · Cited by 112 · see citing works

Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression

Buss, H., Handschick, K., Jurrmann, N., Pekkonen, P., Beuerlein, K., Müller, H., Wait, R., Saklatvala, J., Ojala, P. M., Schmitz, M. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051847 · Cited by 92 · see citing works

Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines

Schmitz, M. L., Weber, A., Roxlau, T., Gaestel, M., & Kracht, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.019 · Cited by 92 · see citing works

Beyond the cell cycle: A new role for Cdk6 in differentiation

Grossel, M. J., & Hinds, P. W. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20712 · Cited by 85 · see citing works

LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains

Wang, Y., & Gilmore, T. D. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00077-5 · Cited by 83 · see citing works

Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation

Bockstaele, L., Bisteau, X., Paternot, S., & Roger, P. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01823-08 · Cited by 80 · see citing works

Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma

Nagel, S., Leich, E., Quentmeier, H., Meyer, C., Kaufmann, M., Drexler, H. G., Zettl, A., Rosenwald, A., & MacLeod, R. (2007) · Leukemia · doi:10.1038/sj.leu.2405028 · Cited by 77 · see citing works

Diversity and regulation in the NF-κB system

Wietek, C., & O'Neill, L. A. J. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.05.003 · Cited by 76 · see citing works

Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination

Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G. N., Kracht, M., Schmitz, M. L., & Burstein, E. (2011) · Oncogene · doi:10.1038/onc.2011.253 · Cited by 70 · see citing works

TRIP6: An adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity

Lin, V. T. G., & Lin, F. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.004 · Cited by 65 · see citing works

Karyotype analyses of 20 human glioma cell lines

Westphal, M., H�nsel, M., Hamel, W., et al. (1994) · Acta Neurochirurgica · doi:10.1007/bf01476489 · Cited by 65 · see citing works

Toll-like Receptor-4 (TLR4) Down-regulates MicroRNA-107, Increasing Macrophage Adhesion via Cyclin-dependent Kinase 6

Hennessy, E. J., Sheedy, F. J., Santamarı́a, D., Barbacid, M., & O'Neill, L. A. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256206 · Cited by 64 · see citing works

Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1

Diefenbacher, M. E., Sekula, S., Heilbock, C., Maier, J. V., Litfin, M., van Dam, H., Castellazzi, M., Herrlich, P. A., & Kassel, O. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0574 · Cited by 57 · see citing works

Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein–dependent and –independent pathways by cyclin‐dependent kinase 4/6

Nonomura, Y., Nagasaka, K., Hagiyama, H., Sekine, C., Nanki, T., Tamamori‐Adachi, M., Miyasaka, N., & Kohsaka, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21927 · Cited by 38 · see citing works

Suppression of p65 phosphorylation coincides with inhibition of IκBα polyubiquitination and degradation

Hu, J., Haseebuddin, M., Young, M. R., et al. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20142 · Cited by 31 · see citing works

Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor

Li, M., Lockwood, W., Zieleńska, M., Northcott, P. A., Shing, Y., Bouffet, É., Yoshimoto, M., Rutka, J. T., Yan, H., Taylor, M. D., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.03.002 · Cited by 30 · see citing works

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Deng, J., Wang, E. S., Jenkins, R. W., Li, S., Dries, R., Yates, K., Chhabra, S., Huang, W., Liu, H., Aref, A. R., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0915 · Cited by 770 · see citing works

Development of dual and selective degraders of cyclin-dependent kinases 4 and 6

Jiang, B., Wang, E. S., Donovan, K. A., Liang, Y., Fischer, E. S., Zhang, T., & Gray, N. S. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901336 · Cited by 272 · see citing works

TF-PROTACs Enable Targeted Degradation of Transcription Factors

Liu, J., Chen, H., Kaniskan, H. Ü., Xie, L., Chen, X., Jin, J., & Wei, W. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03852 · Cited by 247 · see citing works

CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation

Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204 · see citing works

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., Krämer, A., Root, D. E., Barbie, D. A., Krivtsov, A. V., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558114 · Cited by 170 · see citing works

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115 · see citing works

Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs

De Dominici, M., Porazzi, P., Xiao, Y., Chao, A., Tang, H.-Y., Kumar, G., Fortina, P., Spinelli, O., Rambaldi, A., Peterson, L. F., et al. (2020) · Blood · doi:10.1182/blood.2019003604 · Cited by 94 · see citing works

The Activation of IL-1-Induced Enhancers Depends on TAK1 Kinase Activity and NF-κB p65

Jurida, L., Soelch, J., Bartkuhn, M., Handschick, K., Müller, H., Newel, D., Weber, A., Dittrich-Breiholz, O., Schneider, H., Bhuju, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.001 · Cited by 51 · see citing works

Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Adamia, S., Bhatt, S., Wen, K., Chyra, Z., Fell, G. G., Tai, Y.-T., Pioso, M. S., Abiatari, I., Letai, A., Dorfman, D. M., et al. (2022) · Leukemia · doi:10.1038/s41375-021-01475-z · Cited by 24 · see citing works

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Preprint

Polyak, K., Kato, J., Solomon, M., Sherr, C., Massagué, J., Roberts, J., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,949 · see citing works

Cell cycle progression without cyclin E/CDK2

Gladden, A. B., & Diehl, J. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00217-4 · Cited by 67 · see citing works

Cyclin E–Cdk2 Activation Is Associated with Cell Cycle Arrest and Inhibition of DNA Replication Induced by the Thymidylate Synthase Inhibitor Tomudex

Yin, M.-B., Guo, B., Panadero, A., et al. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4346 · Cited by 29 · see citing works

FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α

Wierstra, I., & Alves, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.008 · Cited by 31 · see citing works

The cell-cycle regulated transcription factor B-Myb is phosphorylated by Cyclin A/Cdk2 at sites that enhance its transactivation properties

Saville, M. K., & Watson, R. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202503 · Cited by 81 · see citing works